Related Experiment Video
Updated: May 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Dose-dependent pathogenicity and inflammatory imbalance in severely immunodeficient mice infected with mpox virus
Na Li1, Ziqing Jia1, Zhe Cong1
1NHC Key Laboratory of Human Disease Comparative Medicine, National Center of Technology Innovation for Animal Model, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Abstract:
The global spread of mpox continues to pose a threat to public health, with immunocompromised patients being at greater risk for severe disease. This study aimed to establish a lethal severe infection model using NPG (NOD.Cg-Prkdcscid Il2rgtm1/Vst) mice, a strain with profound immunodeficiency, to simulate severe mpox in immunocompromised patients and investigate disease progression, viral replication kinetics, tissue tropism, and immune responses. In our study, mice were inoculated with three doses of mpox virus (high: 2 × 107, medium: 2 × 106, low: 2 × 105 TCID50 [50% tissue culture infective dose]) or phosphate-buffered saline as a negative control. Body weight, clinical signs, and survival were monitored. Viral loads in plasma and tissues, histopathological changes, and inflammatory responses were evaluated to systematically characterize the pathogenicity of mpox virus in severely immunodeficient mice. The results showed that NPG mice were highly susceptible to mpox virus, showing a clear dose-dependent response. The high-dose group exhibited 100% lethality, and the medium-dose group had a 50% survival rate, whereas the low-dose and control groups survived throughout the study. Plasma and tissue viral loads, as well as histopathological severity, followed a dose-dependent pattern. Viremia remained persistently high, and animals that died at different time points exhibited uniformly high viral loads across multiple tissues. By day 10 postinfection, markedly elevated levels of pro-inflammatory cytokines were detected in plasma, whereas anti-inflammatory cytokines remained largely uninduced. We found that the infection of severely immunodeficient mice with mpox virus results in dose-dependent lethality, persistent high viral loads, and a pronounced pro-/anti-inflammatory imbalance. These findings provide important insights into the pathogenesis of mpox in immunocompromised populations and develop a practical animal model for evaluating therapeutic interventions.
Insights
This study developed a severe mpox infection model in immunodeficient NPG mice, revealing dose-dependent lethality and high viral loads. This model aids in understanding mpox in immunocompromised individuals.
Area of Science:
- Virology
- Immunology
- Animal Models
Background:
- Mpox poses a significant public health threat, particularly to immunocompromised individuals.
- Severe mpox outcomes are a concern in vulnerable populations.
Purpose of the Study:
- To establish a lethal severe mpox infection model in NPG mice.
- To simulate mpox in immunocompromised patients.
- To investigate mpox pathogenesis, viral kinetics, and immune responses in this model.
Main Methods:
- NPG mice were inoculated with varying doses of mpox virus.
- Clinical signs, survival, viral loads, and histopathology were monitored.
- Inflammatory cytokine profiles were analyzed.
Main Results:
- NPG mice exhibited dose-dependent susceptibility and lethality to mpox virus.
- High viral loads were observed in plasma and multiple tissues.
- A significant pro-inflammatory cytokine imbalance was detected.
Conclusions:
- The NPG mouse model effectively simulates severe mpox in immunocompromised hosts.
- Findings offer insights into mpox pathogenesis and inform therapeutic strategies.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
08:38Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Published on: February 22, 2019